In 1991, about 300,000 Americans age 45 and over were admitted to hospitals with hip fractures. Osteoporosis was the underlying cause of most of these injuries. White women 65 or older have twice the incidence of fractures as African-American women. Alendronate is approved for treatment of glucocorticoid-induced osteoporosis in men and women. Risedronate is approved for prevention and treatment of glucocorticoid-induced osteoporosis in men and women.
Medical experts agree that osteoporosis is highly preventable.
However, if the toll of osteoporosis is to be reduced, the commitment to osteoporosis research must be significantly increased. It is reasonable to project that with increased research, the future for definitive treatment and prevention of osteoporosis is very bright. Please contact us to learn more about NOF, National Osteoporosis Prevention Month , or how to become a member . All Rights Reserved. Please read our legal disclaimer and privacy statement .